These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11761949)

  • 21. High excretion of etheno adducts in liver fluke-infected patients: protection by praziquantel against DNA damage.
    Dechakhamphu S; Yongvanit P; Nair J; Pinlaor S; Sitthithaworn P; Bartsch H
    Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1658-64. PubMed ID: 18628417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002.
    Jepsen P; Vilstrup H; Tarone RE; Friis S; Sørensen HT
    J Natl Cancer Inst; 2007 Jun; 99(11):895-7. PubMed ID: 17551150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver fluke-associated cholangiocarcinoma.
    Watanapa P; Watanapa WB
    Br J Surg; 2002 Aug; 89(8):962-70. PubMed ID: 12153620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China.
    Tao LY; He XD; Qu Q; Cai L; Liu W; Zhou L; Zhang SM
    Liver Int; 2010 Feb; 30(2):215-21. PubMed ID: 19840244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A clinical study of cholangiocarcinoma caused cholestasis in Thailand.
    Juttijudata P; Chiemchaisri C; Palavatana C; Churnratanakul S
    Surg Gynecol Obstet; 1982 Sep; 155(3):373-6. PubMed ID: 6287656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholangiocarcinoma: update and future perspectives.
    Gatto M; Bragazzi MC; Semeraro R; Napoli C; Gentile R; Torrice A; Gaudio E; Alvaro D
    Dig Liver Dis; 2010 Apr; 42(4):253-60. PubMed ID: 20097142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cholangiocarcinoma developing in von Meyenburg complexes in haemochromatosis].
    Wisniewski B; Tordjman G; Tran Van Nhieu J; Bettan L; Courillon-Mallet A
    Gastroenterol Clin Biol; 2002 Oct; 26(10):922-4. PubMed ID: 12434102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spatial analysis of hepatobiliary abnormalities in a population at high-risk of cholangiocarcinoma in Thailand.
    Thinkhamrop K; Suwannatrai AT; Chamadol N; Khuntikeo N; Thinkhamrop B; Sarakarn P; Gray DJ; Wangdi K; Clements ACA; Kelly M
    Sci Rep; 2020 Oct; 10(1):16855. PubMed ID: 33033306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opisthorchiasis: a clinicopathologic study of 154 autopsy cases.
    Choompol Koompirochana ; Dhira Sonakul ; Kitkasem Chinda ; Tinrat Stitnimankarn
    Southeast Asian J Trop Med Public Health; 1978 Mar; 9(1):60-4. PubMed ID: 212836
    [No Abstract]   [Full Text] [Related]  

  • 30. "Late development of cholangiocarcinoma after the treatment of hepatolithiasis".
    Khan TF
    J Am Coll Surg; 1994 Jul; 179(1):127-8. PubMed ID: 8019717
    [No Abstract]   [Full Text] [Related]  

  • 31. Cholangiocarcinoma: the "other" liver cancer on the rise.
    Davila JA; El-Serag HB
    Am J Gastroenterol; 2002 Dec; 97(12):3199-200. PubMed ID: 12492212
    [No Abstract]   [Full Text] [Related]  

  • 32. Intrahepatic cholangiocarcinoma: a malignancy of increasing importance.
    Hammill CW; Wong LL
    J Am Coll Surg; 2008 Oct; 207(4):594-603. PubMed ID: 18926465
    [No Abstract]   [Full Text] [Related]  

  • 33. Intrahepatic cholangiocarcinoma: new insights in pathology.
    Sempoux C; Jibara G; Ward SC; Fan C; Qin L; Roayaie S; Fiel MI; Schwartz M; Thung SN
    Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholangiocarcinoma presenting as pyogenic liver abscess: is its outcome influenced by concomitant hepatolithiasis?
    Jan YY; Yeh TS; Chen MF
    Am J Gastroenterol; 1998 Feb; 93(2):253-5. PubMed ID: 9468254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of printing company workers newly diagnosed with occupational cholangiocarcinoma.
    Kubo S; Kinoshita M; Takemura S; Tanaka S; Shinkawa H; Nishioka T; Hamano G; Ito T; Abue M; Aoki M; Nakagawa K; Unno M; Hijioka S; Fujiyoshi T; Shimizu Y; Mizuguchi T; Shirabe K; Nishie A; Oda Y; Takenaka K; Kobarai T; Hisano T; Saiura A; Numao H; Toda M; Kuwae Y; Nakanuma Y; Endo G
    J Hepatobiliary Pancreat Sci; 2014 Nov; 21(11):809-17. PubMed ID: 25088751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study.
    Lee TY; Lee SS; Jung SW; Jeon SH; Yun SC; Oh HC; Kwon S; Lee SK; Seo DW; Kim MH; Suh DJ
    Am J Gastroenterol; 2008 Jul; 103(7):1716-20. PubMed ID: 18557716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, Northeast Thailand.
    Sriamporn S; Pisani P; Pipitgool V; Suwanrungruang K; Kamsa-ard S; Parkin DM
    Trop Med Int Health; 2004 May; 9(5):588-94. PubMed ID: 15117303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current epidemiology of cholangiocarcinoma in Western countries.
    Vithayathil M; Khan SA
    J Hepatol; 2022 Dec; 77(6):1690-1698. PubMed ID: 35977611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Animal studies on liverfluke infestation, dimethylnitrosamine, and bileduct carcinoma.
    Bhamarapravati N; Thamavit W
    Lancet; 1978 Jan; 1(8057):206-7. PubMed ID: 74628
    [No Abstract]   [Full Text] [Related]  

  • 40. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study.
    Shaib YH; El-Serag HB; Nooka AK; Thomas M; Brown TD; Patt YZ; Hassan MM
    Am J Gastroenterol; 2007 May; 102(5):1016-21. PubMed ID: 17324130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.